Ureaplasma urealyticum tracheal colonization and respiratory disease in newborns

Respiratory Care

Volumn 41, Issue 1, 1996, Pages 22-29

  Cordero, Leandro ^a   Davis, Kim ^b   Warner, Douglas ^c   Ayers, Leona W ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; HUMAN; INFECTION RISK; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN MORTALITY; PREMATURITY; TRACHEITIS; UREAPLASMA UREALYTICUM;

EID: 0030027810     PISSN: 00989142     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Tafari N, Ross S, Naeye RL, Judge DM, Marboe C. Mycoplasma T strains and perinatal death. Lancet 1976;1(7951):108-109.
2. Waites KB, Crouse DT, Cassell GH Systemic neonatal infections due to Ureaplasma urealyticum. Clin Infect Dis 1993, 17(Suppl 1):131S-135S.
3. Cassell GH, Waites KB, Crouse DT. Perinatal mycoplasmal infections. Clin Perinatol 1991:18(2):241-262.
4. Cassell GH, Waites KB, Watson HL, Crouse DT, Harasawa R. Ureaplasma urealytincum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev 1993:6(1):69-87.
5. Sanchez PJ Perinatal transmission of Ureaplasma urealyticum: current concepts based on review of the literature. Clin Infect Dis 1993;17(Suppl 1):107S-111S.
6. Waites KB, Crouse DT, Philips JB 3d, Canupp KC, Cassell GH. Ureaplasmal pneumonia and sepsis associated with persistent pulmonary hypertension of the newborn. Pediatrics 1989;83(1):79-85
7. Wang EE, Frayha H, Watts J, Hammerberg O, Chemesky MA, Mahony JB. Cassell GH. Role of Ureaplasma urealyticum and other pathogens in the development of chronic lung disease of prematurity. Pediatr Infect Dis J 1988;7(8):547-551.
8. Cassell GH, Waites KB, Crouse DT, Rudd PT. Canupp KC, Stagno S, Cutter GR. Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants Lancet 1988;2(8605):240-245.
9. Sanchez PJ, Regan JA. Ureaplasma urealyticum colonization and chronic lung disease in low birth weight infants. Pediatr Infect Dis J 1988:7(8):542-546.
10. Payne NR, Steinherg SS, Ackerman P, Chrenka BA, Sane SM, Anderson KT, Fangman JJ. New prospective studies of the association of Ureaplasma urealyticum colonization and chronic lung disease. Clin Infect Dis 1993;17(Suppl 1):117S-121S.
11. Jonsson B, Karell A-C, Ringertz S, Rylander M, Faxelius G. Neonatal Ureaplasma urealyticum colonization and chronic lung disease. Acta Paedriatr 1994:11(1):33-36.
12. Horowitz S, Landau D, Shinwell ES, Zmora E, Dagan R. Respiratory tract colonization with Ureaplasma urealyticum and bronchopulmonary dysplasia in neonates in southern Israel. Pediatr Infect Dis J 1992;11(10):847-851.
13. Cordero L, Davis K, Warner D, Ayers LW Ureaplasma Urealyticum Tracheal Colonization of Mechanically Ventilated Newborn (abstract). Pediatr Res 1994;35:267A.
14. Heggie AD, Jacobs MR, Butler VT, Baley JE, Boxerbaum B. Frequency and significance of isolation of Ureaplasma urealyticum and Mycoplasma hominis from cerebrospinal fluid and tracheal aspirate specimens from low birth weight infants. J Pediatr 1994;124(6):956-961.
15. Wang KE, Cassell GH, Sanchez PJ, Regan JA, Payne NR. Liu PP. Ureaplasma urealyticum and chronic lung disease of prematurity: critical appraisal of the literature on causation. Clin Infect Dis 1993;17(Suppl 1):112S-116S.
16. Avery GB, Fletcher AB. Kaplan M, Brudno DS. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 1985;71(1):106-111.
17. Harkavy KL, Scanlon JW, Chowdhry PK, Grylack LJ. Dexamethasone therapy for chronic lung disease in ventilator and oxygen-dependent infants: a controlled trial. J Pediatr 1989:115(6):979-983.
18. Northway WH Jr, Rosan CR. Porter DY. Pulmonary disease following respiratory therapy of hyaline-membrane disease. N Engl J Med 1967;276(7):357-368.
19. Bancalari E, Abdenour GE, Feller R, Cannon J. Bronchopulmonary dysplasia: clinical prevention. J Pediatr 1979;95(5, Part 2):819-823.
20. Gersony WM. Neonatal pulmonary hypertension: pathophysiology, classification, and etiology. Clin Perinatol 1984;11(3):517-524.
21. Clyde, WA, Kenny GE, Schacter JA. Laboratory diagnosis of chlamydial and mycoplasmal infections. Cunitech 19. Washington DC: American Society for Microbiology, 1984.
22. Afifi AA, Clark V. Computer-aided multivariate analysis. Belmont CA: Lifetime Learning Publications, 1990.
23. Brunell PA, Dische RM, Walker MB. Mycoplasma, ammionitis, and respiratory distress syndrome. JAMA 1969;207:2097-2099.
24. Walsh WF, Stanley S, Lally K, Stribley RE, Treece DP, McCleskey F, Null DM. Ureaplasma urealyticum demonstrated by open lung biopsy in newborns with chronic lung disease. Pediatr Infect Dis, J 1991;10(11):823-827.
25. Wang EEL, Ohlsson A, Kellner JD. Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity: Results of a meta-analysis. J Pediatr 1995;127:640-644.
26. Waites KB, Duffy LB, Searcey KB, Cassell GH. Importance of broth-to-agar inoculation and serial dilution for isolating Ureaplasma urealyticum from endotracheal aspirates (abstract). Program and Abstracts from the Annual Meeting, American Society of Microbiology, Washington DC 1995;300.
27. Syrogiannopoulos GA, Kapatais-Zoumbos K, Decavalas GO, Markantes CG, Katsarou VA, Beratis NG. Ureaplasma urealyticum colonization of full term infants: prenatal acquisition and persistence during early infancy. Pediatr Infect Dis J 1990;9(4):236-240.
28. Eschenbach DA. Ureaplasma urealyticum and premature birth. Clin Infect Dis 1993;17(Suppl 1):100S-106S.
29. Rojas J, Stahlman M. The effect of group B streptococcus and other organisms on the pulmonary vasculature. Clin Perinatol 1984;11(3):7 591-599.
30. Gibson RL, Truog WE, Redding GJ. Nonspecific thromboxane mediated pulmonary hypertension in neonatal Gram-positive sepsis (abstract). Am Rev Respir Dis 1987;135:124.
31. Shankaran S, Farooki ZQ, Desai R. β-Hemolytic streptococcal infection appearing as persistent fetal circulation. Am J Dis Child 1982;136(8):725-727.
32. Kinsella JP, Abman SH. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr 1995;126(6):853-864.
33. Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia Pediatr Clin North Am 1994;41(2):277-313.
34. Parker RA, Lindstrom DP, Cotton RB. Improved survival accounts for most, but not all of the increase in bronchopulmonary dysplasia. Pediatrics 1992;90(5):663-668.
35. Werthammer J, Brown ER, Neff RK, Taeusch, HW Jr. Sudden infant death syndrome in infants with bronchopulmonary dysplasia. Pediatrics 1982;69(3):301-304.
36. Meny RG, Blackmon L, Fleischmann D, Gutberlet R, Naumburg E. Sudden infant death and home monitors. Am J Dis Child 1988;142 (10):1037-1040.
37. Gray PH, Rogers Y. Are infants with bronchopulmonary dysplasia at risk for sudden infant death syndrome? Pediatrics 1994;93(5):774-777.
38. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988;82(4):527-532.
39. Avery ME, Tooley WH, Keller JG, Hurd SS, Bryan MH, Cotton RB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987;79(1):26-30.
40. Stenmark KR, Eyzagirre M, Westcott JY. Henson PM, Murphy RC Potential role of eicosanoids and platelet activating factor in the pathophysiology of BPD. Am Rev Respir Dis 1987;136(3):770-772.
41. Stancombe BB Walsh WF, Derdak S, Dixon P, Hensley D. Induction of human neonatal pulmonary fibroblast cytokines by hyperoxia and Ureaplasma urealyticum. Clin Infect Dis 1993;17(Suppl 1):154S-157S.
42. Crouse DT, English K. Mycoplasma induction of TNF alpha from RAW 264.7 cells, (abstract). Pediatr Res 1995;37:329A.
43. Rudd PT, Carrington D A prospective study of chiamydial mycoplasmal, and viral infections in a neonatal intensive care unit. Arch Dis Child 1984;59(2).120-125.
44. Stagno S, Brasfield DM, Brown MB. Cassell GH, Pifer LL. Whitley RJ, Tiller RE. Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis. and Ureaplasma: a prospective study. Pediatrics 1981;68(3):322-327.
45. Crouse DT, Cassell GH, Waites KB, Foster JM, Cassady G. Hyperoxia potentiates Ureaplasma urealyticum pneumonia in newborn mice. Infect Immun 1990;58(11):3487-3493.
46. Walsh WF, Buttler J, Coalson J, Hensley D, Cassell GH, deLemos RA. A primate model of Ureaplasma urealyticum infection in the premature infant with hyaline membrane disease. Clin Infect Dis 1993; 17(Suppl 1):158S-162S
47. Blanchard A. Hentschel J, Duffy L, Baldus K, Cassell GH. Detection of Ureaplasma urealyticum by polymerase chain reaction in the urogenital tract of adults, in amniotic fluid and in the respiratory tract of newborns. Clin Infect Dis 1993;17(Suppl 1):148S-153S.
48. Scheurlen W, Frauendienst G, Schrod L, von Stockhausen HB. Polymerase chain reaction-amplification of urease genes: rapid screening for ureaplasma urealyticum infection in endotracheal aspirates of ventilated newborns. Eur J Pediatr 1992;151(10):740-742.
49. Quinn Pa, Li CH, Th'ng C. Dunn M, Butany J. Serological response to Ureaplasma urealyticum in the neonate. Clin Infect Dis 1993;17 (Suppl 1):136S-143S.
50. Lau K, Zheng X, Cassell GH, Watson HL. Identification of epitopes of a major antigen of Ureaplasma urealyticum (abstract). Pediatr Res 1995;37;294.
51. Toce SS, Farrell PM, Leavitt LA, Samuels DP, Edwards DK. Clinical and roentgenographic scoring systems for assessing bronchopulmonary dysplasia. Am J Dis Child 1984;138(6):581-585.
52. Waites KB, Crouse DT. Cassell GH. Therapeutic considerations for Ureaplasma urealyticum infections in neonates. Clin Infect Dis 1993; 17(Suppl 1):208S-214S
53. Waites KB, Sims PJ, Crouse DT, Geerts MH, Shoup RE. Hamrick WB, et al. Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection. Pediatr Infect Dis J 1994;13(4):287-293.
54. Groenendaal F, Angulo AF. Ureaplasma urealyticum in tracheal aspirate of ventilated premature infants: report of 6 cases. Tijdschr Kindergeneeskd 1993:61(1):20-24.
55. Abele-Horn M, Hentschel J. Ureaplasma urealyticum in newborn and premature infants Its association with bronchopulmonary dysplasia. Dtsch Med Wochenschr 1992;117(11):408-414.
56. Baier J, Fajardo C. Early screening and treatment of U. urealyticum in the VLBW infant does not prevent chronic lung disease (abstract). Pediatr Res 1993;35:273A.
57. Satow K, Groneck P, Schutt-Gerowitt H. Roth B, Benz-Bohm G. Ureaplasma urealyticum - a new. problem pathogen in neonatology. Monatsschr Kinderhelkd 1991;139(6):344-348.
58. Gjuric G, Prislin-Muskic M, Zurga B, Nikolic E. Cordasic R, Stanojevic M. Ureaplasma urealyticum infection in newborns: three case reports. Eur J Pediatr 1993,152(7) 599-600.
59. Waites KB, Crouse DT, Cassell GH. Antibiotic susceptibilities and therapeutic options for Ureaplasma urealyticum infections in neonates. Pediatr Infect Dis J 1992;11(1):23-29.